Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: Gynecologic Oncology Group study 9921.
D. S. Dizon
No relevant relationships to disclose
M. Sill
No relevant relationships to disclose
N. S. Gould
No relevant relationships to disclose
S. C. Rubin
No relevant relationships to disclose
S. D. Yamada
No relevant relationships to disclose
R. DeBernardo
No relevant relationships to disclose
R. S. Mannel
No relevant relationships to disclose
E. L. Eisenhauer
No relevant relationships to disclose
L. R. Duska
No relevant relationships to disclose
P. M. Fracasso
No relevant relationships to disclose